Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Compare ongoing fees across top dividend ETFs for 2024 to find the funds with the lowest drag on your returns and best value.
28,084 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Apple reports strong Q2 2026 results, led by iPhone demand and Services, while signaling a shift toward ambient AI th...
A grounded, practical look at whether Micron Technology stock can move meaningfully in the next 12 months. Explore dr...
Poly Truth launched its presale with a rapid $170,000 in the first 24 hours, signaling strong appetite for an AI back...
A middle-aged couple with a sizable traditional retirement balance confronts a looming tax spike as required withdraw...
Silver surged and fell in a wild year, turning SLV into a headline idea for investors. This guide walks through what ...
As market conditions shift, financial institutions are prioritizing customer value matters more to shape loan product...
The United States designated Nobitex, Iran’s largest crypto exchange, along with three other Iranian digital-asset pl...
June data show existing home sales beat forecasts, signaling ongoing demand strength in 2026. The numbers point to st...
With the 2026 World Cup in North America on the horizon, per-player earnings from prize money could swing widely depe...
As baby boomers turn caregiving, millions of families juggle medical bills and reduced wages. The shifting care econo...
Bitcoin moved in a wide range this week as hawkish policy signals and geopolitical uncertainty weighed on risk assets...